Susie Huang is a Vice Chairman of Investment Banking and a Managing Director in the Mergers & Acquisitions Department at Morgan Stanley, medical based in New York.
Susie was a Financial Analyst at Morgan Stanley from 1984-86 and rejoined in 1990 as an Associate, cialis both in the M&A Department. She worked in the Firm’s Hong Kong office in 1993-94, was named a Vice President in 1994, Principal in 1996 and Managing Director in 1999. Susie has worked on a number of notable transactions, including: the sale of Cubist to Merck; the sale of Taminco to Eastman Chemical; the sale of Wyeth to Pfizer, the sale of Pharmasset to Gilead, P&G’s RMT/split-off of Folgers with Smuckers and its sale of Pringles, GlaxoSmithKline’s acquisition of Human Genome Sciences, Shire’s acquisition of Viropharma, Alkermes’ acquisition of Elan Drug Technologies, the sale of Chattem to sanofi-aventis, Philips’ acquisition of Respironics, Reckitt Benckiser’s acquisition of Schiff Nutrition, and BP’s sale of Innovene. She chairs the Firm’s Executive Women’s Conference for Morgan Stanley’s senior women and clients. She serves on the Board of Visitors for the John Sloan Dickey Center at Dartmouth College and on the Business Committee of the Metropolitan Museum of Art.
Susie earned an AB in History from Dartmouth College in 1984 and a JD and MBA from Columbia University in 1990.
Phyllis Campbell is the Chairman, troche Pacific Northwest for JPMorgan Chase & Co. She is the firm’s senior executive in Washington, Oregon, and Idaho across businesses, representing JPMorgan Chase & Co. at the most senior level to clients.
Previously, Phyllis served as the President/CEO of The Seattle Foundation, the largest community foundation in Washington. During her tenure, the Foundation doubled in charitable assets, to $600 million. Prior to that, Phyllis was the President/CEO of U.S. Bank of Washington for over six years. Under her leadership, the Bank doubled in size, through customer-focused growth initiatives and acquisitions.
Phyllis has a proven track record of board service, both in the for profit and not-for-profit sectors. She is the lead independent director for Alaska Air Group, a NYSE listed company. She serves on the Nordstrom board of directors and chaired the Audit Committee for seven years. She currently serves on the Diversity Advisory Board (DAB) of Toyota. Phyllis is on the nonprofit boards of PATH, the US-Japan Council, and the global advisory board of Women Corporate Directors (WCD), among others. She is a member of the NACD Governance National Advisory Council. She is a frequently requested speaker on governance, audit and risk-related topics and has spoken at a number of global conferences.
Her awards have included the following: In 2015, she was awarded the Lifetime Achievement Award by Seattle Business Magazine and the Rev. Dr. Martin Luther King Jr. Vision from the Mountaintop Award. In 2014, she was recognized by the National Association of Corporate Directors (NACD) as a “Top 100” Director, as chosen by a committee of her peers and The Ascend/Deloitte Inspirational Award. She was the inaugural NACD Director of the Year Award from the Pacific Northwest chapter, Top Women in Finance Award from Women of Color Magazine in 2010 and Woman Who Makes A Difference Award from the International Women’s Forum. She was also awarded the 36th Regents’ Distinguished Alumnus Award from Washington State University.
Phyllis holds an M.B.A. from the University of Washington’s Executive MBA Program, a B.A. in Business Administration from Washington State University, and is a graduate of the Pacific Coast Banking School at the University of Washington, as well as Stanford University’s Executive Management Program. Phyllis also holds honorary doctorates from Whitworth University and Gonzaga University.